About Us

Nectar Health Sciences is a privately-owned cannabinoid isolation and extraction company. We are a team of experienced scientists and industry experts who are dedicated to commercializing our unique, patent-pending cannabinoid isolation technology. Our research scientists have developed a novel, chemistry-based purification process that isolates cannabinoids to >99% purity.

We have entered the final stages of design and deployment of our proprietary system, developed to meet the growing global demand for plant-derived cannabinoid isolates. Our objective is to deliver industry-leading volumes of the highest quality isolate at the lowest cost.

Leadership Team

Paul Carpanini

CEO & Director

Paul brings over 25 years of experience in mergers and acquisitions, international market expansion and marketing institutional investment management services. Through his experience and qualifications, he has a demonstrated ability in leadership, sound business practices and a track record of assisting with many entrepreneurial start-up ventures. Paul has a solid background in Corporate Business Development and is committed to help uncover new specialized markets and niche opportunities in order to grow the business.

Jan Burian, PhD

Chief Technical Officer

Dr. Jan Burian is a successful Biochemist, with extensive knowledge in operations, production, research and development. Most recently, Dr. Burian served as Associate Director and Site Director for Pfizer Animal Health Canada Inc. where he was responsible for the oversight of R&D, vaccine production, WetLab operation, Quality Operations and Diagnostic Services. In addition to work with Pfrizer, Dr. Burian has numerous academic publications to his name.

Board of Directors

Naomi Yamamoto

Chair

Doug Swift

Director

Scott Lindsay

Director

Dan Polonenko, PhD

Director

Barry Perlmutter

Director

Paul Carpanini

CEO & Director

© copyright 2020 Nectar Health Sciences, Inc.